LRRK2 in infection: friend or foe?

LRRK2 in infection: friend or foe?
Related ArticlesLRRK2 in infection: friend or foe? ACS Infect Dis. 2019 Mar 27;: Authors: Herbst S, Gutierrez M Abstract In the field of Parkinson's disease (PD) research, Leucine-rich repeat kinase 2 (LRRK2) remains one of the most enigmatic kinases. LRRK2 pathogenic mutations result in increased kinase activity, making LRRK2 an attractive therapeutic target for PD. For over 10 years, the ... read more
Source: PubMedPublished on 2019-03-28